Nehal Masood, MD

Nehal Masood, MD, is board-certified in internal medicine and medical oncology. He treats breast, colon, lung and kidney cancers and provides treatment for lymphomas and other hematological conditions. Dr. Masood is a frequent lecturer and is widely published. His cancer research has earned numerous awards. He is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American Association for Cancer Research.

The services Dr. Masood provides include:

• Bone marrow biopsies
• Cytotoxic chemotherapy
• Immunotherapy
• Stem cell therapy
• Treatment of solid tumors

Languages: English, Hindu, Urdu

Certification: American Board of Internal Medicine - Medical Oncology

Professional School: )Dow Medical College (Karachi, Pakistan

Residency: University of Illinois (Chicago, IL)

Fellowship: Fred Hutchinson Cancer Research Center - University of Washington (Seattle, WA)

Medical Groups: MultiCare, MultiCare Medical Associates

Medical Association Memberships:

• American Society of Clinical Oncology
• American Society of Hematology

Research: Chih-Hsin Yang J, Camidge DR, Yang CT, Zhou J, Guo R, Chiu CH, Chang GC, Shiah HS, Chen Y, Wang CC, Berz D, Su WC, Yang N, Wang Z, Fang J, Chen J, Nikolinakos P, Lu Y, Pan H, Maniam A, Bazhenova L, Shirai K, Jahanzeb M, Willis M, Masood N, Chowhan N, Hsia TC, Jian H, Lu S. Safety, Efficacy and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients with EGFR-mutated Advanced NSCLC: a Multicenter, Open-label, Phase I Trial. J Thorac Oncol. 2020 Sep 8:S1556-0864(20)30714-0. doi: 10.1016/j.jtho.2020.09.001. Epub ahead of print. PMID: 32916310. 

Practice Philosophy: I believe that everyone deserves to be treated with dignity and respect and when I interact with patients and their loved ones, I understand that they are dealing with complex issues, looking for hope and need a physician who can help. I want to ensure that my patients have the knowledge they need to make the best decisions about treatment and care. In my practice, I use my training in areas such as molecular biology and genetics to help guide my decisions about a patient's care. There are far more treatment options available than ever before and I find it exciting to provide innovative, breakthrough care to my patients.